Uriarte Huarte Oihane, Richart Lorraine, Mittelbronn Michel, Michelucci Alessandro
Luxembourg Centre for Systems Biomedicine (LCSB), University of Luxembourg, Esch-sur-Alzette, Luxembourg.
Luxembourg Center of Neuropathology, Luxembourg, Luxembourg.
Front Cell Neurosci. 2021 Mar 31;15:660523. doi: 10.3389/fncel.2021.660523. eCollection 2021.
Microglia are the resident immune effector cells of the central nervous system (CNS) rapidly reacting to any perturbation in order to maintain CNS homeostasis. Although their outstanding reactive properties have been elucidated over the last decades, their heterogeneity in healthy tissue, such as across brain regions, as well as their diversity in the development and progression of brain diseases, are currently opening new avenues to understand the cellular and functional states of microglia subsets in a context-dependent manner. Here, we review the main breakthrough studies that helped in elucidating microglia heterogeneity in the healthy and diseased brain and might pave the way to critical functional screenings of the inferred cellular diversity. We suggest that unraveling the cellular and molecular mechanisms underlying specific functionalities of microglial subpopulations, which may ultimately support or harm the neuronal network in neurodegenerative diseases, or may acquire pro- or anti-tumorigenic phenotypes in brain tumors, will possibly uncover new therapeutic avenues for to date non-curable neurological disorders.
小胶质细胞是中枢神经系统(CNS)的常驻免疫效应细胞,能对任何扰动迅速做出反应,以维持中枢神经系统的稳态。尽管在过去几十年里已经阐明了它们出色的反应特性,但它们在健康组织中的异质性,如在不同脑区之间,以及在脑部疾病发生和发展过程中的多样性,目前正在为以依赖于上下文的方式理解小胶质细胞亚群的细胞和功能状态开辟新途径。在这里,我们回顾了主要的突破性研究,这些研究有助于阐明健康和患病大脑中小胶质细胞的异质性,并可能为推断的细胞多样性的关键功能筛选铺平道路。我们认为,揭示小胶质细胞亚群特定功能背后的细胞和分子机制,这最终可能在神经退行性疾病中支持或损害神经网络,或者在脑肿瘤中获得促肿瘤或抗肿瘤表型,可能会为目前无法治愈的神经系统疾病发现新的治疗途径。